Organic cation transporter 1-3 (OCT1-3) (OCT1-3)

The Organic Cation Transporters 1, 2, and 3 (OCT1-3) are a group of polyspecific transporters belonging to the Solute Carrier Family 22 (SLC22A1, SLC22A2, and SLC22A3) that play a fundamental role in the movement of organic cations across cell membranes [1, 4]. These transporters operate via facilitated diffusion, driven by the electrochemical gradient of the substrate, and are independent of sodium or proton gradients [2, 4]. OCT1 is primarily expressed in the liver and is crucial for the hepatic uptake of the first-line antidiabetic drug metformin and several tyrosine kinase inhibitors used in cancer therapy [5, 15]. OCT2 is predominantly localized in the kidney, where it facilitates the renal secretion of cationic drugs and is a major mediator of cisplatin-induced nephrotoxicity [8, 18]. OCT3, also known as the extraneuronal monoamine transporter (EMT), has a broad tissue distribution and is involved in the clearance of monoamine neurotransmitters such as dopamine and serotonin in the brain and heart [11, 18]. Collectively, these transporters are critical in pharmacokinetics, influencing drug absorption, distribution, and elimination [6, 8]. They are also significant sites for clinically relevant drug-drug interactions, where one drug can inhibit the transport of another, leading to altered efficacy or toxicity [5, 14]. Furthermore, common genetic polymorphisms in the SLC22A1-3 genes contribute to significant inter-individual variability in drug response and susceptibility to adverse effects [7, 19].

Other names

SLC22A1SLC22A2SLC22A3Solute carrier family 22 members 1-3OCT1OCT2OCT3EMTExtraneuronal monoamine transporter

Facilitated diffusion of organic cations across the plasma membrane driven by the electrochemical gradient of the substrate.